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Background: The introduction of developmentally adapted criteria for posttraumatic stress disorder (PTSD) has
improved the identification of ≤6-year-old children with clinical needs. Across two studies, we assess predictors of the
development of PTSD in young children (PTSD-YC), including the adult-led acute stress disorder (ASD) diagnosis,
and provide proof of principle for cognitive-focused therapy for this age range, with the aim of increasing treatment
options for children diagnosed with PTSD-YC. Method: Study 1 (N = 105) assessed ASD and PTSD-YC diagnosis in
3- to 8-year-old children within one month and at around three months following attendance at an emergency room.
Study 2 (N = 37) was a preregistered (www.isrctn.com/ISRCTN35018680) randomized controlled early-phase trial
comparing CBT-3M, a cognitive-focused intervention, to treatment-as-usual (TAU) delivered within the UK NHS to 3-
to 8-year-olds diagnosed with PTSD-YC. Results: In Study 1, the ASD diagnosis failed to identify any young children.
In contrast, prevalence of acute PTSD-YC (minus the duration requirement) was 8.6% in the first month post-trauma
and 10.1% at 3 months. Length of hospital stay, but no other demographic or trauma-related characteristics,
predicted development of later PTSD-YC. Early (within one month) diagnosis of acute PTSD-YC had a positive
predictive value of 50% for later PTSD-YC. In Study 2, most children lost their PTSD-YC diagnosis following
completion of CBT-3M (84.6%) relative to TAU (6.7%) and CBT-3M was acceptable to recipient families. Effect sizes
were also in favor of CBT-3M for secondary outcome measures. Conclusions: The ASD diagnosis is not fit for purpose
in this age-group. There was a strong and encouraging signal of putative efficacy for young children treated using a
cognitive-focused treatment for PTSD, and a larger trial of CBT-3M is now warranted. Keywords: Posttraumatic
stress disorder; young children; cognitive behavioral therapy; randomized control trial.
Introduction
Recent editions of diagnostic manuals for mental
health disorders include an increased focus on
identifying posttraumatic stress disorder (PTSD) in
preschool children aged 6 years or younger (e.g. the
PTSD Preschool diagnosis in the Fifth edition of the
Diagnostic and Statistical Manual: DSM-5 (American
Psychiatric Association, 2013); PTSD in the Diag-
nostic Classification of Mental Health and Develop-
mental Disorders of Infancy and Early Childhood
(Zero to Three, 2016)) using developmentally appro-
priate symptom algorithms. This shift emerged fol-
lowing pioneering research demonstrating that
traumatic stress diagnoses derived from adult-led
PTSD criteria fail to identify many young children
with clinical needs in contrast to a developmentally
sensitive ‘alternative algorithm’ (Scheeringa, Myers,
Putnam, & Zeanah, 2012). Developmentally tailored
PTSD diagnoses for young children (PTSD-YC) are
now in widespread use (e.g. De Young, Kenardy, &
Cobham, 2011, Meiser-Stedman, Smith, Glucks-
man, Yule, & Dalgleish, 2008; Scheeringa et al.,
2012; see De Young & Landolt, 2018, for a review),
with a growing number of trials demonstrating that
cognitive behavioral therapy (CBT) can efficaciously
treat PTSD symptoms in this younger age range (e.g.
Haag et al., 2020; Salloum et al., 2016; Scheeringa,
Weems, Cohen, Amaya-Jackson, & Guthrie, 2011).
Here, across two studies, we aimed to further
advance understanding of the course and treatment
options for PTSD-YC diagnosis by exploring (a) early
post-trauma predictors of the course of DSM-5
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PTSD-YC and specifically whether the current DSM-
5 version of the acute stress disorder diagnosis may
also need developmental modification, and (b) pro-
viding proof of concept in 3- to 8-year-olds for a
cognitive-focused therapy for PTSD which has been
shown to be effective in older children and adoles-
cents via an early-stage randomized controlled trial.
Study 1: DSM-5 acute stress disorder and PTSD-
YC in trauma exposed young children
following emergency room attendance
Many young people show natural attenuation of
posttraumatic stress symptoms in the months fol-
lowing exposure (Hiller et al., 2016; Le Brocque
et al., 2020). In terms of very young children, to date,
there have been a small number of longitudinal
studies charting the course of PTSD symptoms and/
or of the PTSD-YC diagnosis using the alternative
algorithm (e.g. De Young et al., 2011; Le Brocque
et al., 2020; Meiser-Stedman et al., 2008; Scheer-
inga, Zeanah, Myers, & Putnam, 2005). In addition,
wait-list control arms of prior CBT studies (e.g.
Scheeringa et al., 2011) have tracked the untreated
course of PTSD symptoms in this age-group. To our
knowledge, there have been no studies evaluating
the early course of the DSM-5 PTSD-YC, as opposed
to severity of symptoms, in very young children.
In older youth, several predictive factors reliably
distinguish children who recover from those who go
on to develop PTSD (only diagnosable at 1 month
post-trauma) (Meiser-Stedman, McKinnon, et al.,
2017; Meiser-Stedman, Smith, et al., 2017; Trickey,
Siddaway, Meiser-Stedman, Serpell, & Field, 2012).
However, we know far less about predictors in very
young children (Le Brocque et al., 2020; Meiser-
Stedman et al., 2008). The first aims of Study 1 were
therefore to examine both the course of, and predic-
tors of, DSM-5 PTSD-YC in very young children.
One such putative predictor is meeting criteria for
DSM-5 acute stress disorder (ASD) within the first
month post-trauma. ASD was introduced in the
DSM-IV to identify in the acute stage those at higher
risk of later PTSD. In 8- to 16-year-olds, the presence
of ASD markedly increases the likelihood of later
PTSD (odds ratio = 26.9; Meiser-Stedman, McKin-
non, et al., 2017). However, despite the significant
update to the PTSD criteria to accommodate very
young children in the DSM-5 there has been no
corresponding change in the ASD criteria which
remain grounded in the adult literature. The further
aims of Study 1 were therefore to examine the utility
of the DSM-5 ASD criteria in very young children
both in detecting early cases of young children in
clinical need and in predicting later PTSD-YC.
One alternative to the current DSM-5 ASD criteria
for very young children would be to use the current
developmentally sensitive DSM-5 PTSD-YC criteria
in the first month post-trauma (i.e. with the usual
PTSD duration criterion removed) in the form of an
‘acute DSM-5 PTSD-YC’ diagnosis. In one study in
children aged 2–6 years, meeting acute PTSD-YC
criteria (based on the alternative algorithm (AA);
Scheeringa et al., 2012) in the month post-trauma
significantly predicted increased risk of later AA-
PTSD-YC (Meiser-Stedman et al., 2008). Our final
aim for Study 1 was therefore to examine the utility
of an acute DSM-5 PTSD-YC diagnosis in identifying
cases and predicting later DSM-5 PTSD-YC.
Previous research has suggested that the PTSD-YC
diagnosis may be a more appropriate conceptualiza-
tion of PTSD beyond the preschool range for children
up to 8 years of age (Danzi & La Greca, 2017;
Hitchcock et al., 2021; Meiser-Stedman et al., 2008).
For this reason, the present study also reports
prevalence estimates for children both up to 6 years
and up to 8 years.
Study 1 therefore addressed five questions: (1)
What is the course of DSM-5 PTSD-YC symptoms in
3- to 6-year-olds (and 3- to 8-year-olds) over the first
3 months post-trauma following attendance at an
Emergency Room? (2) What trauma-related and
demographic factors predict later DSM-5 PTSD-YC?
(3) What is the prevalence of DSM-5 ASD in young
children? (4) Does the DSM-5 ASD diagnosis –
designed to aid early identification of those at risk –
have prognostic utility in this age-group? and (5) Is
‘acute PTSD-YC’ a superior alternative?
Method
Participants. National Health Service ethics approval (12/
EE/0458) was obtained. Participants were 3- to 8-year-old
children and caregivers (N = 105) attending 3 emergency
rooms (ER) in East Anglia, UK, during recruitment phases
between 2014 and 2017. Participants were eligible for inclu-
sion if they were aged 3–8 years and if the event that led to
attendance at the ER met criteria for a traumatic event
according to the DSM-5 (though see De Young & Landolt,
2018, for a discussion of the complexities around this criterion
in younger children). We only included children with a single-
event trauma, that is, for whom no other DSM-5 criterion A
trauma was identified by their parents. Exclusion criteria were
lack of English fluency in either the child or the caregiver,
moderate-to-severe brain injury, and the presence of a child
protection issue.
ER records were screened for trauma event details to
determine eligibility before approaching families. Eligible fam-
ilies were given study information upon or after discharge and
gave informed consent prior to participation. Approximately
27% of approached families agreed to participate. This rate is
similar to that in our prior RCTs for childhood PTSD (e.g.
Meiser-Stedman, Smith, et al., 2017). Reasons for nonpartic-
ipation included caregivers not interested (37%), caregivers
had no time (35%), could not make contact (25%), and
exclusion criterion identified at first contact (2%). The sub-
stantial lack of parental engagement and perceived lack of time
for mental health research recruiting from ER attendance
highlight an important feasibility issue for future research.
Diagnostic assessments. Assessments were conducted
via telephone by trained research staff within the first month
(Time 1) and at around three months (Time 2) after ER
attendance. Diagnoses of DSM-5 ASD (within the first month
post-trauma) and DSM-5 PTSD-YC and adult-algorithm DSM-
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5 PTSD (three months post-trauma) were made via clinical
interview with a parent using the Diagnostic Infant and
Preschool Assessment (DIPA; Scheeringa & Haslett, 2010),
adapted (through correspondence with the DIPA lead author)
for the DSM-5 to cover the preschool PTSD diagnosis as well as
to include criteria for acute stress disorder and with minor
adjustments for oppositional defiance disorder. We also gen-
erated an ‘acute PTSD-YC’ diagnosis at Time 1 (ignoring the
duration criterion) to evaluate whether this had better predic-
tive value than the ASD diagnosis. The DIPA is a psychome-
trically robust parental-report semistructured interview which
was delivered and scored by an Assistant Psychologist, with
scoring for 100% of interviews second-rated using the original
audio files by a registered Clinical Psychologist with extensive
experience treating children with PTSD. Symptoms were
scored as present or absent. Agreement was obtained on
100% of interviews.
Of the 105 children screened at Time 1, 26 did not respond
to repeated attempts to contact at Time 2.
Analytic approach. Multiple imputation: We used
multiple imputation to deal with missing data at Time 2, using
multivariate imputation by chained equations (MICE) (Van
Buuren, 2018) implemented in SPSS v.25. We imputed 25
datasets using a fully conditional specification whereby all
Time 2 variables with missing data were included in the
chained regression models (logistic or linear for categorical and
continuous variables, respectively), alongside Time 1 variables
for which we had complete data, and residual variance was
added to the parameter estimates using a Bayesian approach.
This meant that for any given analysis involving imputed data,
the imputation model for those data had included variables
with complete data that were not themselves included in the
analysis (Van Buuren, 2018).
Prediction of Time 2 diagnostic outcomes: To exam-
ine prediction of PTSD-YC at Time 2 from baseline sample
characteristics, we compared those children who developed
PTSD-YC at Time 2 to those who did not, on Time 1 variables of
age, sex, ethnicity, type of trauma, whether the child lost
consciousness, whether pain killing medication was adminis-
tered, whether there was an admission to hospital, and
number of days in hospital, with analyses pooled across the
25 imputed datasets.
The predictive utilities of the different diagnostic criteria at
Time 1 for the diagnoses at Time 2 were examined using
positive/negative predictive values, where a positive predictive
value represents the likelihood that a child meeting PTSD-YC
criteria at Time 1 would have PTSD-YC at Time 2 and a
negative predictive value represents the likelihood that a child
without the diagnosis at Time 1 would not have the diagnosis
at Time 2. Analyses were pooled across the imputed datasets.
Results
Sample characteristics and prevalence. Sample
characteristics are presented in Table 1. Observed
prevalence rates are presented separately for 3- to 6-
year-olds and 3- to 8-year-olds. At Time 1, in both 3-
to 6-year-olds and 3- to 8-year-olds, strikingly DSM-
5 ASD criteria did not identify any children. Using
acute PTSD-YC criteria, prevalence estimates rose to
9.1% (7/77) in 3- to 6-year-olds and to 8.6% (9/105)
in 3- to 8-year-olds.
At Time 2, the standard DSM-5 PTSD criteria
identified 5.3% (3/57) of 3- to 6-year-olds, and this
doubled to 10.5% (6/57) when using DSM-5 PTSD-
YC. For 3- to 8-year-olds, use of PTSD-YC identified
10.1% (8/79) with PTSD, relative to 6.3% (5/79)
according to the DSM-5 adult criteria.
At Time 1, of those who did not meet criteria for the
full ‘acute PTSD-YC’ diagnosis, 57 (53.8%) did meet
the re-experiencing criterion, 42 (39.6%) the avoid-
ance criterion, and 25 (25.3%) the hyperarousal
criterion. At Time 2, of those who did not meet full
PTSD-YC criteria, 30 (28.6%) did meet the re-
experiencing criterion, 16 (15.2%) the avoidance
criterion, and 16 (15.2%) the hyperarousal criterion.
Predictors of PTSD-YC at Time 2. Data were com-
piled across 3- to 8-year-olds for these analyses to
increase power. Analyses are reported for multiply
imputed data (Van Buuren, 2018). Sensitivity anal-
yses on complete cases revealed no differences in the
pattern of results.
We first compared the Time 1 variables (listed in
Table 1) between those children who went on to
develop PTSD-YC at Time 2 to those who did not.
Neither trauma type (Fisher’s exact p = .34), age
(Mann–Whitney test: d = 0.14, 95% CI [0.41, 0.71],
p = .62), sex (Fisher’s exact p = .70), ethnicity (Fish-
er’s exact p = 1.00), admission to hospital (Fisher’s
exact p = .41), whether the child lost consciousness
Table 1 Sample characteristics at Time 1 for Study 1
Age ≤6 years
(n = 77 unless
otherwise noted)
Age ≤8 years
(n = 105 unless
otherwise noted)
Age (mean (SD)) 4.38 (1.10) range 3–
6
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(Fisher’s exact p = .59), or administration of painkil-
lers (Fisher’s exact p = .61) at Time 1 was associated
with PTSD-YC at Time 2. A greater number of days in
hospital (Mann–Whitney test: d = 0.92, 95% CI
[0.32, 1.51], p = .002) at Time 1 were significantly
associated with Time 2 development of PTSD-YC.
As no children at Time 1 met criteria for DSM-5
ASD, this had no calculable predictive value for later
PTSD-YC. Of the nine children diagnosed with acute
PTSD-YC at Time 1, 4 met DSM-5 PTSD-YC criteria
at Time 2, 4 did not meet criteria at Time 2, and one
was lost to attrition. Of the 95 children not diagnosed
with acute PTSD-YC at Time 1, four were diagnosed
with PTSD-YC at Time 2. There was a modest
positive predictive value of 50% and a high negative
predictive value of 90%, using the imputed data,
comparable to the predictive value of DSM-IV ASD in
older youth (Dalgleish et al., 2008).
Discussion
Consistent with a recent review (De Young & Landolt,
2018), application of the developmentally appropri-
ate DSM-5 PTSD-YC criteria in an ER-attending
sample doubled the prevalence estimate for PTSD
relative to adult DSM-5 PTSD criteria, at 3 months
post-trauma. PTSD-YC appeared to have clinical
utility up to 8 years of age, replicating prior research
(Meiser-Stedman et al., 2008), and this reinforces
suggestions that the developmental stage of all
youth, including older children, should be taken
into consideration when optimizing the conceptual-
ization of posttraumatic stress, as opposed to a
simple binary distinction with the cutoff at 6 years
(De Young & Landolt, 2018).
No young children met DSM-5 ASD criteria (which
importantly remain adult-based in the DSM-5) in the
acute post-trauma phase. In contrast, DSM-5 PTSD-
YC criteria applied in this acute phase (minus the
duration criterion) – acute PTSD-YC – suggested that
~9% of young children had diagnosable levels of
immediate distress. This is not dissimilar to rates
reported in older children (Kassam-Adams et al.,
2012) and in the small number of studies of younger
children in this acute phase (e.g. Haag & Landolt,
2017; Meiser-Stedman et al., 2008). Half of these
children meeting criteria for acute PTSD-YC in the
first month went on to develop PTSD-YC at three
months. Prevalence estimates for PTSD-YC at
3 months were ~10%, and this is not dissimilar to
other studies looking at PTSD-YC at around this time
point post-trauma (e.g. Scheeringa et al., 2005). No
other demographic, trauma-related, or clinical fac-
tors were significantly predictive of later PTSD-YC
other than amount of time in hospital (although
other factors not measured, such as parental factors,
may have shown a different pattern; e.g. Le Brocque
et al., 2020).
There are a number of potential limitations to this
study. A low prevalence of children with ASD and
acute PTSD-YC at Time 1 meant we were not able to
fully explore predicting factors. A large percentage of
families also declined participation. As we were
unable to collect PTSD measures from nonpartici-
pating families, it may be that those experiencing
more difficulty were more likely to volunteer for
research, impacting our prevalence estimates.
Finally, diagnoses, necessarily in this age-group,
relied upon clinical interviews using parent report.
However, with the participating sample, we were
able to gain important understanding of the course
of PTSD-YC in the early months following trauma.
Study findings further validate the introduction of
PTSD-YC into the DSM-5, but suggest that the
current adult-based DSM-5 ASD diagnosis is not fit
for purpose as an acute prognostic algorithm for
young children and requires revision or replacement.
It may be that particular ASD symptoms are insen-
sitive in young children (Dalgleish et al., 2008) or
that the current thresholds for diagnosis in the DSM-
5 are inappropriate (Kassam-Adams et al., 2012).
Given this, it is difficult to recommend ASD for future
study in this age-group.
Study 2: A randomized controlled proof-of-
principle trial of a trauma-focused cognitive
therapy for young children with PTSD-YC
International guidelines recommend individual cog-
nitive behavior therapy (CBT) with a trauma focus for
the treatment of PTSD in adults and older youth
(Australian Centre for Posttraumatic Mental Health,
2007; Bisson et al., 2019; National Institute for
Health & Care Excellence, 2018; World Health
Organization, 2013). However, these guidelines offer
no explicit recommendation for the treatment of
PTSD in young children aged under 5 years. Prior
trials have been very encouraging, suggesting that
developmentally tailored CBT can reduce symptoms
of PTSD in children aged 2–8 years who experience
elevated posttraumatic stress but who do not neces-
sarily meet criteria for a PTSD diagnosis (Deblinger,
Stauffer, & Steer, 2001; Salloum et al., 2016;
Scheeringa et al., 2011). Parent-directed CBT-
based intervention has also been effective in accel-
erating recovery from acute stress symptoms in 1- to
6-year-olds following accidental injury (Haag et al.,
2020). There is therefore a promising evidence base
for variations of CBT in treating young children.
The availability of multiple evidence-based treat-
ments for a condition offers sufferers and their
families an important degree of choice. Based on
our prior clinical trials with older children (e.g.
Meiser-Stedman, Smith, et al., 2017), we were inter-
ested in whether a CBT for PTSD intervention that is
more cognitive in its formulation compared to that
used in extant trials may also be adaptable for this
younger sample. Our trauma-based cognitive ther-
apy protocol for young children – CBT-3M (Goodall
et al., 2017) – includes a strong focus on three Ms:
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cognitive restructuring of trauma Memories, chal-
lenging maladaptive cognitive appraisals (Meanings),
and remediating unhelpful coping strategies
employed by children and parents/caregivers (Man-
agement). The manual also includes much less of an
emphasis on exposure relative to other protocols, as
some therapists can be hesitant to use exposure with
young children (Whiteside, Deacon, Benito, & Ste-
wart, 2016). Instead, the CBT-3M protocol focuses
predominantly on restructuring and updating the
trauma memory narrative (through drawings, play,
and talking) with new information that challenges or
contradicts the maladaptive meanings associated
with the trauma that are embedded in the narrative
(see Goodall et al., 2017, for a detailed case study).
We therefore built upon prior work by (a) develop-
ing a CBT-3M manual building on the protocol used
by Scheeringa et al. (2011) but enriching the cogni-
tive elements based on our work with older youth
(Smith, Dalgleish, & Meiser-Stedman, 2018) as out-
lined above; (b) conducting a proof-of-principle ran-
domized controlled trial (RCT) to explore whether
CBT-3M (versus treatment-as-usual; TAU) is likely to
deliver remission from PTSD-YC in young children.
This is therefore not a definitive evaluation of CBT-
3M but an earlier stage RCT to provide a point
estimate of putative efficacy as a platform for later
phase trials (Dalgleish et al., 2015); and (c) providing
important information about acceptability and fea-
sibility of CBT-3M and of the feasibility of a later-
stage trial.
The RCT represents the first UK trial of a CBT
intervention for PTSD-YC and is the first to include
only those children who meet criteria for a DSM-5
PTSD-YC diagnosis, as opposed to elevated symptom
levels, where recovery from diagnosis is the primary
outcome – a factor that may be important for
healthcare systems where diagnosis acts as a gate-
way to care.
As a result of the findings from Study 1 showing
that PTSD-YC identifies children with PTSD up to
age 8 years who are missed by the standard PTSD
diagnosis alongside the other similar data that
prompted the age cutoff in Study 1 (Danzi & La
Greca, 2017; Hitchcock et al., 2021; Meiser-
Stedman et al., 2008), and in accordance with the
slightly wider age range recruited in some prior CBT
trials providing treatment to young children experi-
encing PTSD (e.g. Salloum et al., 2016), we recruited
young children with PTSD-YC up to 8 years of age.
Method
Trial design and procedure. The RCTwas preregistered
(www.isrctn.com/ISRCTN35018680) and ethically approved
(Cambridge South: MREC 12/EE/0458). Full details of design,
measures, and recruitment are in the published protocol
(Dalgleish et al., 2015). All participants were recruited in the
East of England from a variety of sources including ERs
(including participants from Study 1 who had PTSD at
3 months post-trauma), schools, general medical practices,
secondary care child mental health services, social services,
and via self-referral. Figure 1 shows the CONSORT diagram
prior to cross-over at post-treatment. Recruitment took place
from December 2013 until April 2018. There were periods of
time when recruitment was stalled or significantly slowed
(around 9 months in total) due to staffing changes and the
necessity for retraining, and/or part-time working in the trial
team. Initial recruitment rates were also slower due to the need
to establish a recruitment network. Once recruitment path-
ways were established and fully resourced, recruitment rates
were around 3-4 young people per month of whom around 1 in
3 met inclusion criteria and for whom the parent(s) agreed to
take part in the trial.
Inclusion criteria were being aged 3–8 years and having
experienced a single incident trauma according to the DSM-5
definition (see Study 1) and diagnosis of DSM-5-Preschool
PTSD-YC assessed via clinical interview using the DIPA.
Exclusion criteria were the presence of head trauma (Glasgow
Coma Score < 8); learning disability, but not specific learning
difficulties; a diagnosis of autism; another primary psychiatric
diagnosis that warrants treatment using a psychological
therapy ahead of the traumatic stress response; inability to
speak English within the family; ongoing exposure to threat;
and a history of organic brain damage. Victims of chronic
sexual or physical abuse were invited into the trial because of
the need to involve specialist services.
A wider range of trauma compared to Study 1 were experi-
enced by the 37 participants including a burn (n = 1), acci-
dental injury (e.g. dog attack; n = 9), acute medical emergency
(n = 2), home invasion (n = 4), road traffic accident (n = 3),
physical or sexual assault or other interpersonal event involv-
ing threat of injury/life (n = 9), or witnessing an event in which
a family member (parent, sibling, or grandparent) experienced
threat to life/serious injury (n = 9).
Participants were randomized to treatment with stratifica-
tion for age, gender, and symptom severity (based on the DIPA),
by an independent statistician. The treating clinical psychol-
ogist was informed of allocation after the baseline assessment
via email from the statistician. All assessments were completed
by trained research staff, who were blind to treatment alloca-
tion. Outcomes were assessed pretreatment, within two weeks
of post-treatment and, for those in the CBT-3M arm, at three-
month follow-up. Upon completion of the post-treatment
assessment, children in TAU who still met PTSD-YC criteria
were offered CBT-3M. The planned twelve-month follow-up for
the CBT-3M arm was unfeasible given lower than anticipated
completion rates at three-month follow-up. No adverse events
were reported.
Outcomes
Primary outcome. The primary outcome was recov-
ery from DSM-5 PTSD-YC at post-treatment, using
the parent-report DIPA (Scheeringa & Haslett, 2010).
As in Study 1, a registered Clinical Psychologist
agreed on diagnosis for 100% of the interviews,
which were completed by trained research staff who
were blind to treatment allocation.
Secondary outcomes. Secondary outcomes were
comorbid diagnoses of major depressive disorder
(MDD), attention deficit hyperactivity disorder
(ADHD), oppositional defiant disorder (ODD), gener-
alized anxiety disorder (GAD), specific phobia and
separation anxiety disorder (SAD) on the DIPA, and
changes on the parent-completed Young Child PTSD
Checklist (Scheeringa, 2010) (Cronbach’s
alpha = .85 for this study) to index symptoms of
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PTSD, the parent-completed Pediatric Emotional
Distress Scale (to index general distress; Saylor,
Swenson, Stokes Reynolds, & Taylor, 1999) (Cron-
bach’s alpha = .84 for this study), and parent-
completed Preschool Feelings Checklist (to index
emotional functioning; Luby, Heffelfinger, Koenig-
McNaught, Brown, & Spitznagel, 2004) (Cronbach’s
alpha = .74 for this study).
Feasibility and acceptability. Attrition at each
assessment point indicated trial and intervention
feasibility and acceptability. A random 50% of fam-
ilies (to reduce participant burden) completing CBT-
3M were also asked to rate, out of ten, whether (1)
‘this kind of treatment seems to make sense’, (2) ‘I
think this treatment is going to help us’, (3) ‘I would
tell a friend to try this treatment with their child’, and
(4) ‘the therapist is keen to help my child’. Additional
formal acceptability measures outlined in the trial
protocol (Dalgleish et al., 2015) – for example, the
Therapeutic Alliance Scale (Shirk, Karver, & Brown,
2011) – were withdrawn in order to reduce clinician
and participant burden.
Interventions. CBT-3M: The CBT-3M treatment
manual is available online (https://c2ad.mrc-cb
u.cam.ac.uk/resources/). The intervention was
adapted from our 12-session intervention for older
youth (Meiser-Stedman, Smith, et al., 2017; Perrin
et al., 2017; Smith et al., 2007) and the prior trial
protocol from Scheeringa (Scheeringa et al., 2011).
As noted in the Introduction, the protocol is more
cognitive than that used in prior trials and targets
three key mechanisms: trauma Memories, maladap-
tive appraisals (Meanings), and adaptive coping
(Management). Twelve sessions, delivered weekly,
involve a combination of the therapist and child
alone, therapist and parent alone, and parent and
Excluded  (n=73)




Analysed per protocol (n=15)
Lost to post-treatment assessment (n=4)
(n=1 withdrew consent, n=3 did not respond to
attempts to contact)
Allocated to treatment as usual (n= 19)
Received allocated intervention (n= 19)
Lost to post-treatment assessment (n=5)
(n=1 unavailable within assessment window, 
n=4 moved out of area)
Allocated to CBT-3M (n= 18)
Received allocated intervention (n= 18)
Analysed intent-to-treat (n=18)






Baseline assessment (n= 37)
NHS services n=22
School nurse/SENCO n=6
Other research studies n=7
Self-referral n=2
Assessed for eligibility (n= 110)
from Dec 2013- April 2018
Figure 1 CONSORT diagram for randomized controlled trial of CBT-3M versus treatment-as-usual (TAU), prior to cross-over post-
treatment
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child with the therapist, with each session involving
a combination of these three elements. Treatment
fidelity and adherence was maintained through
supervision with manual authors (Dalgleish and
Smith).
Treatment-as-usual: Given that PTSD-YC as a
diagnosis has no explicit treatment guidelines in
the United Kingdom, TAU was expected to vary from
no intervention, to diverse forms of psychosocial
support. Caregivers in both trial arms were given
some basic psychoeducation about PTSD symptoms
in young children in the initial assessment. Com-
parison against TAU allowed us to assess what
intervention young children with PTSD commonly
receive through the UK NHS. Participants allocated
to TAU who did not receive a multi-session psycho-
logical intervention were assessed for ‘post-
treatment’ at 13–15 weeks postbaseline to maximize
comparability with CBT-3M.
Overview of analyses. Analyses were completed by
an independent statistician who was blind to treat-
ment allocation. We tested for between-arm differ-
ences using the nonparametric Quade’s test (Quade,
1967) to account for the modest sample size. This
represents a deviation from our protocol where we
discussed using parametric analyses (Dalgleish
et al., 2015). Intent-to-treat (ITT) analysis was com-
pleted following multiple imputation of post-
treatment variables across 40 datasets using the
same MICE and imputation modeling approach as
that outlined for Study 1 (Bodner, 2008; van
Buuren, 2018) such that baseline variables with
complete data, alongside the trial arm variable, were
included in the imputation models.
As an early-phase proof-of-principle trial, the RCT
was not powered to detect statistically significant
effects on outcomes but rather to derive point
estimates of effect size for the efficacy of CBT-3M to
inform later fully powered definitive trial investiga-
tions (see trial protocol paper; Dalgleish et al., 2015).
In addition to the reported data, we collected
information on health service usage on the complete
cases to evaluate feasibility for collecting such data
to inform health economics analyses in later-stage
trials.
Results
Baseline characteristics, treatment completion,
and acceptability. The baseline characteristics of
the sample are presented in Table 2.
Of the nineteen children allocated to TAU, four did
not complete post-treatment assessments (21%
attrition): one family pursued treatment elsewhere
and withdrew and three were uncontactable. Within
TAU, only one child received any form of psycholog-
ical intervention; the rest received no specific
trauma-related support. Following the TAU period,
caregivers of four of those children who still met
criteria for PTSD declined treatment with CBT-3M;
one child had received treatment elsewhere, two
reported that it was no longer required, and one did
not respond to efforts to contact. The remainder
received the intervention.
For CBT-3M, in all but one case the parent who
attended with their child was the mother. Within the
CBT-3M arm, all participants completed the 12
intervention sessions (where participants were
unable to attend, sessions were rescheduled in order
to deliver the full dose of the intervention). Sessions
took place at the local general practice, child mental
health clinic, at the university treatment center, or in
the child’s home. Five CBT-3M participants did not
attend the post-treatment assessment (29% attri-
tion); one was unavailable in the assessment win-
dow, and four could not be contacted as they had
moved away from the area. There was no significant
difference for gender (TAU: Fisher’s exact = 1.55,
p = .21; CBT-3M: Fisher’s exact = 1.29, p = .26), age
(TAU: t = 0.26, p = .80; CBT-3M: t = 1.01, p = .37),
symptoms on the YCPC (TAU: t = 1.28, p = .22; CBT-
3M: t = 1.25, p = .24), nor PTSD impairment score
indexed by the DIPA at baseline (TAU: t = 0.39,
p = .70; CBT-3M: t = 1.09, p = .29) between com-
plete cases and those lost to attrition.
In terms of acceptability, means (out of 10; n = 9)
for caregiver ratings of CBT-3M indicated that the
treatment made sense to the family (M = 9.36,
SD = 1.03) and that caregivers felt: The therapy
Table 2 Baseline clinical characteristics for Study 2
TAU (n = 19)
CBT-3M
(n = 18)
Mean (SD) Mean (SD)
Number female (%) 10 53% 9 50%
Age (range 3–8) 6.5 (1.9) 6.0 (1.7)
Time since trauma (months) 9.22 (9.30) 11.88 (8.50)
Young Child PTSD
Checklist
33.97 (14.63) 33.54 (15.66)
Preschool Feelings
Checklist
28.71 (11.19) 29.73 (9.68)
Pediatric Emotional
Distress Scale
51.40 (8.42) 51.71 (10.05)
Comorbid MDDa 7 39% 8 47%
Comorbid ADHDb 5 26% 3 19%
Comorbid ODDb 10 53% 10 63%
Comorbid specific phobiab 10 53% 11 69%
Comorbid social phobiac 2 11% 3 18%
Comorbid GADa 0 0% 2 12%
Comorbid separation
anxietyb
10 53% 8 50%
Comorbid diagnoses scored using the DIPA. ADHD, attention
deficit hyperactivity disorder; GAD, generalized anxiety disor-
der; MDD, major depressive disorder; ODD, oppositional
defiant disorder.
an = 18 for TAU and n = 17 for CBT-3M.
bn = 16 for CBT-3M.
cn = 17 for CBT-3M.
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would help (M = 8.91, SD = 1.70); the therapist
wanted to help their family (M = 9.73, SD = 0.90);
and they would recommend CBT-3M to a friend
(M = 9.18, SD = 1.25).
Primary outcome. In all cases, apart from one (with
the father), CBT-3M outcome assessments were
completed with the participant’s mother. Of the
complete cases, on the primary endpoint of DSM-5
PTSD-YC diagnosis at post-treatment, 84.6%
(n = 11) CBT-3M participants lost their PTSD-YC
diagnosis, relative to 6.7% (n = 1) TAU participants;
a significant difference using intent-to-treat analysis
on the imputed data OR = 0.022 [0.002, 0.270],
p = .003, and corroborated with per protocol analy-
ses involving only the complete cases: OR = 0.019
[0.002, 0.214]; p = .001.
Secondary outcomes. The observed secondary out-
come data are presented in Table 3. Intent-to-treat
analysis on the imputed datasets for these secondary
outcomes using Quade’s test indicated a significant,
large effect size in favor of CBT-3M at post-treatment
for scores on the Preschool Feelings Checklist,
t(7.45) = 4.07, d = 1.34, 95% CI [0.62, 2.05],
p = .004. Medium-sized, though (as expected) non-
significant, effect size estimates were observed for
the Young Child PTSD Checklist, t(6.17) = 1.89,
d = 0.62, 95% CI [0.05, 1.28], p = .11, and Pedi-
atric Emotion Distress Scale, t(6.82) = 1.44,
d = 0.47, 95% CI [0.19, 1.12], p = .19. A large
effect was found in favor of CBT-3M for the Fear
subscale of the PEDS, though again this did not
reach statistical significance, t(5.91) = 2.32,
d = 0.76, 95% CI [0.09, 1.42], p = .06.
Odds ratios were in favor of CBT-3M for remission
of comorbid diagnoses (although they did not attain
traditional levels of significance); major depressive
disorder, OR = 0.20; 95% CI [0.02, 1.67], p = .14;
oppositional defiant disorder, OR = 0.19, 95% CI
[0.02, 2.19], p = .18; and specific phobia, OR = 0.62,
95% CI [0.04, 9.95], p = .73 Data were too sparse to
fit logistic models for other comorbid disorders.
At three-month follow-up (for CBT-3M only due to
cross-over trial design), all 8 of the assessed partic-
ipants did not meet criteria for PTSD-YC.
Discussion
Building on pioneering prior work (Meiser-Stedman,
McKinnon, et al., 2017; Scheeringa et al., 2012;
Smith et al., 2007), Study 2 provides proof of
principle from an early-phase RCT that a trauma-
based CBT package with a strong cognitive element
and minimal exposure-based work, shown to be
efficacious in older youth, can be successfully
adapted to treat PTSD in children as young as three
years within the UK healthcare system. Eighty-four
per cent of treated young children lost their diagno-
sis (relative to ~7% in TAU), with good acceptability.
This RCT is not a definitive trial but one intended to
provide important information on feasibility, accept-
ability, and the strength of the signal of efficacy as a
platform for later-stage definitive evaluations of CBT-
3M. Improving access to evidence-based treatment
in this younger age-group is particularly important
as children in the TAU trial arm (with one exception)
received no psychological intervention from the UK
NHS (limiting our conclusions regarding treatment
efficacy against an active intervention), which is
likely due in part to the lack of UK guidance on
available evidence-based interventions for this age-
group (National Institute for Health & Care Excel-
lence, 2018).
The study highlighted important feasibility issues,
in particular the completion of follow-up assess-
ments, which will be important to consider when
designing a later-stage trial. Specifically, a number
of families who completed the intervention stage of
the trial were unavailable for the post-treatment
outcome assessment, in the majority of cases
because the families had moved away from the area.
Closer attention to making alternative arrangements
for assessment in these circumstances will be
required.
General discussion
Following the presentation of developmentally sen-
sitive criteria to characterize PTSD in young children
(Scheeringa et al., 2012) culminating in the intro-
duction of a subtype-PTSD diagnosis for preschool-
ers (PTSD-YC) in the DSM-5 (American Psychiatric
Association, 2013), the nature of traumatic stress
has now been extensively elaborated in the youngest
trauma victims. Our findings reinforce the impor-
tance of using developmentally appropriate PTSD-YC
criteria when evaluating posttraumatic stress in
young children.
Study 1 demonstrated that the current adult-
based DSM-5 diagnosis of acute stress disorder is
not fit for purpose in this younger age-group, failing
Table 3 Mean (standard deviation) symptom scores at post-treatment, by group allocation for Study 2
Young children PTSD Checklist PEDS-total PEDS-fear Preschool feelings checklist
TAU 34.80 (20.86) 45.60 (14.60) 13.00 (4.42) 30.20 (19.72)
CBT-3M 16.43 (19.27) 40.50 (14.53) 8.63 (5.48) 15.86 (11.47)
Table displays observed means. CBT-3M, cognitive behavior therapy-3M (Meanings, Memories, and Management); PEDS, Pediatric
Emotional Distress Scale; TAU, treatment-as-usual.
© 2021 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
Child and Adolescent Mental Health.
8 Caitlin Hitchcock et al.
to identify a single child in the acute phase with
clinically significant distress. In contrast, applying
the developmentally appropriate PTSD-YC criteria
immediately post-trauma identified around 9% of
young children with diagnosable levels of problems –
a level comparable to estimates of acute distress
found in other studies, including those with older
youth (Haag & Landolt, 2017; Meiser-Stedman et al.,
2008; see De Young & Landolt, 2018). This suggests
that developmental adjustment of traumatic stress
in the DSM-5 requires extension to the acute-phase
diagnosis within the first few weeks post-trauma.
Our findings suggest significant enduring morbidity
in young children in the absence of suitable inter-
vention; only around 50% of those identified as at
risk in the acute phase of Study 1 recovered by
3 months, while minimal recovery was reported with
TAU in Study 2.
As we are now able to identify young children
burdened by debilitating PTSD, it is imperative that
we continue to develop and expand on suitable
interventions for this age-group to provide choice
for therapists and families. Here, we have provided
proof-of-principle support that a trauma-based cog-
nitive therapy (CBT-3M) can be successfully adapted
for younger children (with a slightly broader range of
traumas relative to Study 1) ensuring that the same
intervention protocol has applicability across the
young age range from 3–18 years (Meiser-Stedman,
Smith, et al., 2017). A fully powered, definitive trial is
now necessary to evaluate treatment efficacy and
identify mechanisms of action, as well as extending
evaluation of the intervention to more complex
presentations.
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Key points
 The DSM-5 PTSD in young children (PTSD-YC) diagnostic subtype may have clinical utility up to 8 years of age.
 The DSM-5 acute stress disorder diagnosis is not fit for purpose in very young children and requires revision.
 A cognitive-focused treatment for PTSD (CBT-3M) showed promising preliminary efficacy for 3- to 8-year-
olds.
 A larger trial of CBT-3M is now warranted to increase treatment options for this vulnerable age-group.
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